Under terms of the definitive agreement, Healthscreen has agreed to pay a total of $1.3 million for Regent. The purchase price is payable in cash of $1 million on closing and $300,000 on the date that is six months after closing, either in cash or in Healthscreen shares.
Eugene Bomba, CFO of Healthscreen, said: “This acquisition is immediately accretive to Healthscreen’s cash flow, and allows us to deploy a portion of the $4.25 million debt financing we closed last month. The purchase price for Regent represents 1.8 times trailing recurring revenue.”